參考文獻(xiàn)/References:
[1] Lim S H,Dubielecka P M,Raghunathan V M.Molecular targeting in acute myeloid leukemia[J].Journal of Translational Medicine,2017,15(1):183.[2] Xu J,Huang B,Liu X,et al.Poor prognosis in acute myeloid leukemia patients with monosomal karyotypes[J].Turk J Haematol,2017,34(2):126-130.[3] Stolzel F,Mohr B,Kramer M,et al.Karyotype complexity and prognosis in acute myeloid leukemia[J].Blood Cancer Journal,2016,6(1):e386.[4] Anelli L,Pasciolla C,Zagaria A,et al.Monosomal karyotype in myeloid neoplasias:a literature review[J].Onco Targets Ther,2017,10:2163-2171.[5] 焦揚(yáng).不同染色體核型的初治原發(fā)性急性髓系白血病的臨床特點(diǎn)分析[J].中華醫(yī)學(xué)遺傳學(xué)雜志,2018,35(5):727-732.[6] 張之南,沈悌.血液病診斷及療效標(biāo)準(zhǔn)[M].3版.北京科學(xué)出版社,2008:103-115.[7] 劉林,徐歡,陳志妹,等.515例急性髓系白血病患者年齡特異的細(xì)胞遺傳學(xué)分析[J].中華醫(yī)學(xué)遺傳學(xué)雜志,2019,36(6):552-555.[8] 劉艷春,李偉,王歡,等.染色體核型動(dòng)態(tài)監(jiān)測(cè)對(duì)急性白血病患者化療療效評(píng)估的作用[J].中國(guó)實(shí)驗(yàn)血液學(xué)雜志,2015,23(3):658-662.[9] Xu X Q,Wang J M,Gao L,et al.Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients[J]. American Journal of Hematology,2014,89(9):874-881.[10] McCurdy S R,Levis M J.Emerging molecular predictive and prognostic factors in acute myeloid leukemia[J]. Leuk Lymphoma,2018,59(9): 2021-2039.[11] 趙婷,主鴻鵠,王婧,等.早期評(píng)估NPMl突變陽(yáng)性急性髓系白血病患者殘留白血病水平的預(yù)后意義[J].中華血液學(xué)雜志,2017,38(1):10-16.[12] Haferlach C,Dicker F,Herholz H,et al.Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype[J].Leukemia,2008,22(8):1539-1541.